Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Doherty

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Human Psychopharmacology|August 5, 2021
A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adultsAmy Bullock, Handan Gunduz-Bruce, Gary K Zammit, et al.
The Journal of Trauma and Acute Care Surgery|December 9, 2021
The tight rope act: A multicenter regional experience of tourniquets in acute trauma resuscitationLeah Carey Tatebe, Victoria Schlanser, David Hampton, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|September 15, 2020
Treatment of Partial Thickness Burns: A Prospective, Randomized Controlled Trial Comparing Four Routinely Used Burns Dressings in an Ambulatory Care SettingShivani Aggarwala, Varun Harish, Sarah Roberts, et al.
Environmental Management|October 15, 2013
Bridging disciplines, knowledge systems and cultures in pest managementWill Allen, Shaun Ogilvie, Helen Blackie, et al.
Sleep Medicine|December 28, 2023
A real-world observational study assessing relationships between excessive daytime sleepiness and patient satisfaction in obstructive sleep apneaSairam Parthasarathy, Danielle Hyman, James Doherty, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 25, 2018
Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor EncephalitisNatasha Warikoo, Samuel J Brunwasser, Ann Benz, et al.
JAMA Psychiatry|June 30, 2021
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical TrialKristina M Deligiannidis, Samantha Meltzer-Brody, Handan Gunduz-Bruce, et al.
The Journal of Clinical Psychiatry|December 28, 2023
Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder: Interim Results From the Open-Label, Phase 3 SHORELINE StudyAndrew J Cutler, Gregory W Mattingly, Susan G Kornstein, et al.
Journal of Affective Disorders|April 4, 2022
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorderEllison Suthoff, Mark Kosinski, Alix Arnaud, et al.
The American Journal of Psychiatry|July 26, 2023
Zuranolone for the Treatment of Postpartum DepressionKristina M Deligiannidis, Samantha Meltzer-Brody, Bassem Maximos, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Human Psychopharmacology|August 5, 2021
A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adultsAmy Bullock, Handan Gunduz-Bruce, Gary K Zammit, et al.
The Journal of Trauma and Acute Care Surgery|December 9, 2021
The tight rope act: A multicenter regional experience of tourniquets in acute trauma resuscitationLeah Carey Tatebe, Victoria Schlanser, David Hampton, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|September 15, 2020
Treatment of Partial Thickness Burns: A Prospective, Randomized Controlled Trial Comparing Four Routinely Used Burns Dressings in an Ambulatory Care SettingShivani Aggarwala, Varun Harish, Sarah Roberts, et al.
Environmental Management|October 15, 2013
Bridging disciplines, knowledge systems and cultures in pest managementWill Allen, Shaun Ogilvie, Helen Blackie, et al.
Sleep Medicine|December 28, 2023
A real-world observational study assessing relationships between excessive daytime sleepiness and patient satisfaction in obstructive sleep apneaSairam Parthasarathy, Danielle Hyman, James Doherty, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 25, 2018
Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor EncephalitisNatasha Warikoo, Samuel J Brunwasser, Ann Benz, et al.
JAMA Psychiatry|June 30, 2021
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical TrialKristina M Deligiannidis, Samantha Meltzer-Brody, Handan Gunduz-Bruce, et al.
The Journal of Clinical Psychiatry|December 28, 2023
Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder: Interim Results From the Open-Label, Phase 3 SHORELINE StudyAndrew J Cutler, Gregory W Mattingly, Susan G Kornstein, et al.
Journal of Affective Disorders|April 4, 2022
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorderEllison Suthoff, Mark Kosinski, Alix Arnaud, et al.
The American Journal of Psychiatry|July 26, 2023
Zuranolone for the Treatment of Postpartum DepressionKristina M Deligiannidis, Samantha Meltzer-Brody, Bassem Maximos, et al.
Pageof 5